Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018

BACKGROUND: Patients infected with the novel coronavirus (SARS-CoV-2) are being treated empirically with oseltamivir, but there is little evidence from randomised controlled trials to support the treatment of coronavirus infections with oseltamivir. AIM: To determine whether adding oseltamivir to us...

Descripción completa

Detalles Bibliográficos
Autores principales: Coenen, Samuel, van der Velden, Alike W, Cianci, Daniela, Goossens, Herman, Bongard, Emily, Saville, Benjamin R, Gobat, Nina, de Paor, Muireann, Ieven, Margareta, Verheij, Theo J, Butler, Christopher C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311109/
https://www.ncbi.nlm.nih.gov/pubmed/32571773
http://dx.doi.org/10.3399/bjgp20X711941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311109/
https://www.ncbi.nlm.nih.gov/pubmed/32571773
http://dx.doi.org/10.3399/bjgp20X711941

Ejemplares similares